I’d like to start this article by wishing all of you a very happy 2023! Hopefully, it will prove to be more rewarding from an investment standpoint than the exceedingly disappointing 2022. Also disappointing is the recent, January 3rd, policy change by the Food and Drug Administration (FDA) that allows pharmacies to sell mifepristone. What…